DK1810676T3 - Levetiracetam formuleringer og fremgangsmåder til deres fremstilling - Google Patents
Levetiracetam formuleringer og fremgangsmåder til deres fremstillingInfo
- Publication number
- DK1810676T3 DK1810676T3 DK06251210T DK06251210T DK1810676T3 DK 1810676 T3 DK1810676 T3 DK 1810676T3 DK 06251210 T DK06251210 T DK 06251210T DK 06251210 T DK06251210 T DK 06251210T DK 1810676 T3 DK1810676 T3 DK 1810676T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- preparation
- levetiracetam
- compositions
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76210306P | 2006-01-24 | 2006-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1810676T3 true DK1810676T3 (da) | 2009-02-09 |
Family
ID=36337638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06251210T DK1810676T3 (da) | 2006-01-24 | 2006-03-07 | Levetiracetam formuleringer og fremgangsmåder til deres fremstilling |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070172521A1 (da) |
EP (1) | EP1810676B1 (da) |
JP (1) | JP2009524658A (da) |
CN (1) | CN101360493A (da) |
AT (1) | ATE413875T1 (da) |
CA (1) | CA2637925A1 (da) |
DE (1) | DE602006003617D1 (da) |
DK (1) | DK1810676T3 (da) |
ES (1) | ES2317452T3 (da) |
IL (1) | IL193024A0 (da) |
PL (1) | PL1810676T3 (da) |
PT (1) | PT1810676E (da) |
WO (1) | WO2007086891A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2197428B1 (en) * | 2007-10-16 | 2012-01-25 | Pharmathen S.A. | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
US20120003307A1 (en) * | 2007-11-29 | 2012-01-05 | Ranbaxy Laboratories Limited | Levetiracetam controlled release composition |
EP2291177A2 (en) * | 2008-05-05 | 2011-03-09 | Farmaprojects, S.A. | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
US20100159009A1 (en) * | 2008-12-24 | 2010-06-24 | Zhongshui Yu | Controlled-release formulations |
US20100172979A1 (en) * | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
ME02765B (me) | 2009-09-18 | 2018-01-20 | Sanofi Sa | (z)-2-cijan0-3-hidroksi-but-2-enske kiseline (4'-trifluormetilfenil) -amid formulacije tableta sa poboljšanom stabilnošću |
CN101693017B (zh) * | 2009-10-28 | 2012-06-06 | 北京赛科药业有限责任公司 | 左乙拉西坦的药物组合物及其制备方法 |
EP2563340A2 (en) | 2010-04-26 | 2013-03-06 | Mahmut Bilgic | Water soluble pharmaceutical composition |
US8906949B2 (en) * | 2010-05-21 | 2014-12-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of zolmitriptan and process for preparing the same |
CN102379857B (zh) * | 2011-05-30 | 2013-10-09 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦缓释药物组合物及其制备方法 |
CN102764254B (zh) * | 2012-05-16 | 2016-09-07 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦药物组合物及其制备方法 |
JP6630229B2 (ja) * | 2016-05-17 | 2020-01-15 | エルメッド株式会社 | レベチラセタム含有医薬組成物及びその製造方法 |
JP6422464B2 (ja) * | 2016-05-19 | 2018-11-14 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
JP6326114B2 (ja) * | 2016-11-01 | 2018-05-16 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4514389A (en) * | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB9319732D0 (en) * | 1993-09-24 | 1993-11-10 | Ucb Sa | Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety |
EP1244456B1 (en) * | 1999-12-01 | 2007-05-09 | Ucb, S.A. | A pyrrolidineacetamide derivative for treatment of chronic or neuropathic pain |
US20040116506A1 (en) * | 2002-06-20 | 2004-06-17 | Krusz John Claude | Use of levetiracetam for treating or preventing acute headaches |
CN1205938C (zh) * | 2002-10-08 | 2005-06-15 | 深圳海王药业有限公司 | 具有改善哺乳动物微循环作用的产品 |
WO2004069796A2 (en) * | 2003-02-03 | 2004-08-19 | Teva Pharmaceutical Industries Ltd. | Process for producing levetiracetam |
TR200503397T1 (tr) * | 2003-03-18 | 2007-03-21 | Hetero Drugs Limited | Levetirasetam'ın yeni kristal formları. |
EP1663968A1 (en) * | 2003-09-05 | 2006-06-07 | Ranbaxy Laboratories Limited | Process for the preparation of pure levetiracetam |
EA014961B1 (ru) * | 2005-07-26 | 2011-04-29 | Юсб Фарма С.А. | Фармацевтические композиции, включающие леветирацетам, и способы их получения |
-
2006
- 2006-03-07 WO PCT/US2006/008298 patent/WO2007086891A1/en active Application Filing
- 2006-03-07 JP JP2008552284A patent/JP2009524658A/ja active Pending
- 2006-03-07 AT AT06251210T patent/ATE413875T1/de not_active IP Right Cessation
- 2006-03-07 DK DK06251210T patent/DK1810676T3/da active
- 2006-03-07 PL PL06251210T patent/PL1810676T3/pl unknown
- 2006-03-07 ES ES06251210T patent/ES2317452T3/es active Active
- 2006-03-07 US US11/371,128 patent/US20070172521A1/en not_active Abandoned
- 2006-03-07 DE DE602006003617T patent/DE602006003617D1/de active Active
- 2006-03-07 CN CNA2006800516061A patent/CN101360493A/zh active Pending
- 2006-03-07 EP EP06251210A patent/EP1810676B1/en not_active Revoked
- 2006-03-07 CA CA002637925A patent/CA2637925A1/en not_active Abandoned
- 2006-03-07 PT PT06251210T patent/PT1810676E/pt unknown
-
2008
- 2008-07-24 IL IL193024A patent/IL193024A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007086891A1 (en) | 2007-08-02 |
ATE413875T1 (de) | 2008-11-15 |
IL193024A0 (en) | 2009-02-11 |
DE602006003617D1 (de) | 2008-12-24 |
EP1810676B1 (en) | 2008-11-12 |
JP2009524658A (ja) | 2009-07-02 |
ES2317452T3 (es) | 2009-04-16 |
CN101360493A (zh) | 2009-02-04 |
PT1810676E (pt) | 2009-01-02 |
US20070172521A1 (en) | 2007-07-26 |
CA2637925A1 (en) | 2007-08-02 |
PL1810676T3 (pl) | 2009-04-30 |
EP1810676A1 (en) | 2007-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1810676T3 (da) | Levetiracetam formuleringer og fremgangsmåder til deres fremstilling | |
NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
DK1909764T3 (da) | Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling | |
EP2535058A3 (en) | Stabilization of vaccines by lyophilization | |
NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
UA112281C2 (uk) | Стабільні інсектицидні композиції і способи їх отримання | |
WO2008049116A3 (en) | Substituted indoles | |
DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
DK2460820T3 (da) | PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger | |
DK3320919T3 (da) | Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille sådanne sammensætninger | |
NO20084850L (no) | MGLUR5 modulatorer I | |
DK1845954T3 (da) | Oralt opløsende sammensætning af olanzapin og donepzil | |
DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
EP1962838A4 (en) | Farnesoid X RECEPTOR AGONISTS | |
GEP20094784B (en) | Sustained release pharmaceutical formulations | |
IL192108A (en) | Triazulophyridines, pharmaceutical preparations and combinations containing them, process for their preparation and use as modulators of tyrosine kinase | |
EA200701065A1 (ru) | Инъецируемые составы, содержащие нанодисперсный оланзапин | |
WO2007106746A3 (en) | Formulations for ecallantide | |
NO20084852L (no) | MGLUR5 modulatorer V | |
DK1862158T3 (da) | Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf | |
ATE429906T1 (de) | Trockene aripiprazolformulierungen | |
TW200738649A (en) | Calcilytic compounds | |
BRPI0615135A2 (pt) | composições de fármacos contendo matrizes de hipromelose de liberação controlada | |
UA95253C2 (ru) | Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит | |
DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |